rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1998-3-23
|
pubmed:abstractText |
Previous evaluation of the cost effectiveness of antireflux medication used in gastro-oesophageal reflux disease (GORD) have been based on results obtained in controlled clinical trials. Unfortunately such an approach does not necessarily identify the therapeutic option which provides the greatest benefit from available resources in real life situations. To make an informed choice requires a recognition that the costs and benefits of therapy in practice may differ from those identified in trials.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0017-5749
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
13-6
|
pubmed:dateRevised |
2009-11-18
|
pubmed:meshHeading |
pubmed-meshheading:9505878-Anti-Ulcer Agents,
pubmed-meshheading:9505878-Cisapride,
pubmed-meshheading:9505878-Cost-Benefit Analysis,
pubmed-meshheading:9505878-Databases, Factual,
pubmed-meshheading:9505878-Family Practice,
pubmed-meshheading:9505878-Gastroesophageal Reflux,
pubmed-meshheading:9505878-Humans,
pubmed-meshheading:9505878-Omeprazole,
pubmed-meshheading:9505878-Physician's Practice Patterns,
pubmed-meshheading:9505878-Piperidines,
pubmed-meshheading:9505878-Ranitidine,
pubmed-meshheading:9505878-Retrospective Studies,
pubmed-meshheading:9505878-Treatment Outcome
|
pubmed:year |
1998
|
pubmed:articleTitle |
Cost effectiveness of treatment for gastro-oesophageal reflux disease in clinical practice: a clinical database analysis.
|
pubmed:affiliation |
Janssen Research Foundation, Beerse, Belgium.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|